Echo Health Ventures
57
65M
30
7.12
5
0.47
4
- Stages of investment
- Areas of investment
Summary
In 2016 was created Echo Health Ventures, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Seattle.
Among the most popular portfolio startups of the fund, we may highlight Livongo, DispatchHealth, GNS Healthcare. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Home Health Care, Medical.
We also calculated 10 valuable employees in our database.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2019. Opposing the other organizations, this Echo Health Ventures works on 10 percentage points less the average amount of lead investments. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2019. The average startup value when the investment from Echo Health Ventures is 500 millions - 1 billion dollars. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Echo Health Ventures, startups are often financed by Cambia Health Solutions, Venrock, Threshold. The meaningful sponsors for the fund in investment in the same round are Town Hall Ventures, LRVHealth, HLM Venture Partners. In the next rounds fund is usually obtained by Sandbox Industries, Polaris Partners, LRVHealth.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 57
- Lead investments
- 5
- Exits
- 4
- Rounds per year
- 7.12
- Follow on index
- 0.47
- Investments by industry
- Health Care (56)
- Medical (27)
- mHealth (15)
- Analytics (13)
- Hospital (11) Show 34 more
- Investments by region
-
- United States (57)
- Peak activity year
- 2020
- Number of Unicorns
- 3
- Number of Decacorns
- 3
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 1B
- Group Appearance index
- 0.98
- Avg. company exit year
- 12
- Avg. multiplicator
- 20.44
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Embold Health | 15 Dec 2021 | Analytics, Health Care, Medical | Early Stage Venture | 20M | United States, Nashville, Tennessee |
Sempre Health | 13 Sep 2023 | Health Care, Hospital, Medical | Late Stage Venture | 20M | United States, California, San Francisco |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.